Titanium Dioxide Nanoparticles Induce Cell Cycle Arrest and Apoptosis through Inhibiting PI3K/AKT/mTOR Pathway in

Ruoyun Dong1, Xiaojia Meng2, Hongmei Chang1

  • 1Department of Preventive Medicine / the Key Laboratory for Prevention and Control of Emerging Infectious Diseases and Public Health Security, the Xinjiang Production and Construction Corps, School of Medicine, Shihezi University, Shihezi, 832000, Xinjiang, China.

PubMed

Insights

Titanium dioxide nanoparticles (TiO2 NPs) harm sperm production by causing cell cycle arrest and apoptosis in spermatogonia. This occurs via the PI3K/AKT/mTOR pathway, explaining reduced sperm counts.

Area of Science:

  • Toxicology
  • Cell Biology
  • Nanotechnology

Background:

  • Titanium dioxide nanoparticles (TiO2 NPs) are linked to reduced sperm counts.
  • The underlying mechanisms, particularly concerning spermatogonia, require elucidation.

Purpose of the Study:

  • To investigate TiO2 NPs' effects on spermatogonial cell cycle and apoptosis.
  • To explore the role of the PI3K/AKT/mTOR signaling pathway in these effects.

Main Methods:

  • Mouse spermatogonia (GC-1) were exposed to varying TiO2 NP concentrations.
  • Cell viability, cell cycle, apoptosis, and key signaling proteins were analyzed.
  • PI3K pathway modulation using IGF-1 (agonist) and LY294002 (inhibitor) was performed.

Main Results:

  • TiO2 NPs inhibited proliferation, induced G0/G1 cell cycle arrest, and promoted apoptosis.
  • Downregulation of CDK4, CDK2, Cyclin D1, Cyclin E1, and upregulation of p21, p53 were observed.
  • TiO2 NPs inhibited the PI3K/AKT/mTOR pathway; IGF-1 reversed effects, while LY294002 exacerbated them.

Conclusions:

  • TiO2 NPs induce spermatogonial G0/G1 cell cycle arrest and apoptosis by inhibiting the PI3K/AKT/mTOR pathway.
  • This pathway inhibition is a likely cause of TiO2 NP-induced reduction in sperm numbers.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.6K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.4K
DNA Damage can Stall the Cell Cycle02:37

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K